Inventor

HOELDER SWEN

DE33 patents

⚠️ This page may combine multiple inventors who share the name “HOELDER SWEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOELDER SWEN

CANCER RESEARCH TECH LTD

N2-phenyl-pyrido[3,4-d]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitors

Compounds that inhibit MPS1 kinase

Inhibitor compounds

Inhibitor compounds

BCL6 inhibitors

N2-phenyl-pyrido[3,4-D]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitors

Inhibitor compounds

Inhibitor compounds

2-quinolone derived inhibitors of BCL6

BCL6 inhibitors

Benzimidazolone derived inhibitors of BCL6

Pharmacologically active compounds

Pharmacologically active compounds

[1,4]oxazepino[2,3-c]quinolinone derivatives as BCL6 inhibitors

SANOFI AVENTIS DEUTSCHLAND

4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments

Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them

Pyridazinone derivatives, methods for their production and their use as pharmaceuticals

Substituted an unsubstituted benzooxathiazoles and compounds derived therefrom

Pyridazinone kinase inhibitors

Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them

AVENTIS PHARMA GMBH

Substituted thiadiazolesulfonamides

Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom

Substituted thiadiazolesulfonamides

AVENTIS PHARMA SA

4-benzimidazol-2-ylpyridazin-3-one derivatives

4-benzimidazol-2-ylpyridazin-3-one derivatives

Pyridazinone derivatives

HOELDER SWEN

Fused bicyclic imidazoles

Fused bicyclic pyrimidines

CANCER RES TECH LTD

Inhibitor compounds

CANCER REC TECH LTD

Pharmacologically active compounds

PEDERSEN HENRIK

Enzyme activity screen with direct substrate reloading

NOVOZYMES AS

Enzyme activity screen with direct substrate replacement

BAYER SCHERING PHARMA AG

Fused bicyclic pyrimidines